Providence, Rhode Island is the first location in the United States to offer a mobile methadone service. This article profiles CODAC Behavioral Health who operate a 27 foot RV that has been modified to function as a mobile methadone unit.
The concept behind this innovative approach is to bring essential medication-assisted treatment services to the rural areas of Rhode Island where many prospective patients are underserved.
Access to methadone and buprenorphine-based treatments remains an ongoing challenge as nearly 83% of those with opioid use disorder (OUD) are not yet utilizing medication to help with their opioid withdrawal symptoms. Opioid withdrawal sickness is the primary driver of illicit opioid use, opioid overdose, and lifestyle disruption.
CODAC received their FDA approval in July 2022 to begin dispensing methadone from their mobile unit.
Methadone clinics are a lifesaver for many thousands of recovering individuals across the country. There are a number of new clinics opening each week, but the provision of a methadone mobile service offers an interesting alternative that will be closely watched and evaluated in the years ahead.
The faces of recovery are as diverse as you can imagine. Decades ago, there were common stereotypes of addicts as people who looked a certain way and likely came from a shady side of the tracks.
Today, we now understand that addiction has impacted nearly every family and community across the country. It has crept into mainstream life to such a large extent that the old stereotypes have faded away, and in their place are pictures of everyday people like the ones we know and love.
Opioid addiction is an illness that can be successfully treated. This new reality provides hope and assurance that nearly any person, with proper support and treatment, can successfully manage this illness and regain their life.
However, the odds are not good for individuals who stay in active addiction and who postpone their entry into professional care. With the widespread proliferation of fentanyl and other adulterated street opiates, the risks have never been greater.
In the United States, there are a significant number of methadone clinics, buprenorphine clinics, and qualified physicians who specialize in the treatment of opioid addition using medication-assisted approaches. For the vast majority of opioid addicted people, medication is key in helping them to prevent extremely diffcult opioid withdrawal.
Once withdrawal sickness is effectively eliminated, then counseling & support can help restore a person’s life and open up new paths to the future.
Naltrexone is an opioid treatment medication that works very differently than either methadone or buprenorphine.
Naltrexone functions as an opioid blocker that interferes with the euphoric effects of opiates. Unlike methadone, naltrexone does not eliminate opioid withdrawal. So it is typically only begun following a successful period of opioid detoxification.
Naltrexone is taken as a pill or as a time-released injectable. It blocks the feeling of getting high thus deterring a person from continuing in active drug use with opioids. If there’s no pay off for using, why do it?
Some individuals who don’t necessarily require methadone or buprenorphine can effectively utilize naltrexone as a component of their recovery program. Vivitrol is the time-released, branded version of naltrexone that is taken once monthly as an injection. With Vivitrol, the naltrexone remains active in the bloodstream for 30 days and blocks the effects of heroin or other opiate use. This reinforces one’s focus on recovery choices and can reduce opioid cravings.
Patients receiving naltrexone may develop a lowered tolerance to opioids over time, and should remain aware of the risk of opioid overdose should they relapse. The medication is also used in the treatment of alcohol dependency and has been shown to reduce the euphoric effects of alcohol consumption.
Naltrexone is not to be confused with Naloxone. Naloxone is the opioid overdose reversal medication that has recently been in the news for saving thousands of lives across the country.
The national budget proposal for the 2019 fiscal year includes a request for $13 billion in funding for opioid treatment and related services. This linked Newsweek article states that $3 billion would be allocated in 2018 and another $10 billion in 2019.
Many opioid treatment programs across the country are currently able to add patient slots when additional funding is made available. The opioid crisis has flooded many clinics that are already at maximum census due to limited State and Medicaid funding.
A number of private pay clinics have opened in recent years as the need for medication-assisted treatment increased. If a substantial allocation of government funds becomes available, opioid treatment services will finally come into sharp national focus as scores of people finally obtain the help they need to stabilize and to recover.
In treating opioid addiction, research has shown that traditional abstinence-based programs which do not utilize medication assistance have a failure rate of 90%. Medication-assistance is a critical factor in helping opioid addicted people move into sustained recovery. The proposed $13 billion earmarked for opioid treatment services can make a huge difference all across the U.S. Methadone or buprenorphine (suboxone) coupled with counseling and drug testing comprise the gold standard of care in treating opioid addiction.
Posted in Addiction Recovery, Buprenorphine, Drug Treatment, Methadone, Methadone Benefits, Methadone Clinics, Methadone Maintenance, Methadone News, Opiate Treatment, Suboxone, Suboxone Doctors
The U.S. House of Representatives just passed a sweeping reform, called the 21st Century Cures Act, that will infuse $1 billion in new funding earmarked for opioid treatment and prevention services.
It has taken several years of alarming statistics on the national opioid epidemic, but Congress has responded. This USA Today article provides an overview of the numbers. In addition to the $1 billion for opioid services will be another $4.8 billion for cutting-edge research around treating Alzheimers, cancer, traumatic brain injury, and other medical issues.
The bill received enormous bipartisan support and passed 392-to-26. In 2016, death by drug overdose surpassed death by car crashes and gun fatalities. The public outcry for government intervention has been steady. With so many families having been affected by addiction issues, the new funding allowance should open doors for opioid treatment particularly in rural areas where opioid services have been severely lacking.
Methadone remains the #1 medication-assisted treatment option. Buprenorphine medications are; however, making a big impact in the treatment field with a wide variety of buprenorphine-based formulations coming to market. In addition to the familiar suboxone film, are probuphine (a buprenorphine implant), subutex (an uncoated buprenorphine tablet), and bunavail.
Posted in Addiction Treatment, Buprenorphine, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Naloxone, Naltrexone, Opiate Treatment, Suboxone
Tagged drug legislation, drug treatment funding, opioid treatment